Le Lézard
Classified in: Health
Subjects: NPT, CSR, PSF

Blue Cross Blue Shield of Arizona Invests $10 Million In Fight Against Opioid Misuse And Substance Use Disorder


PHOENIX, Aug. 14, 2018 /PRNewswire/ -- Blue Cross Blue Shield of Arizona (BCBSAZ) joined Governor Doug Ducey today to launch Mobilize AZ, a multi-faceted program to address the misuse of opioids and other substances and reduce overdose-related deaths in Arizona. With BCBSAZ investing $10 million over three years, the initiative will support prevention, treatment, and recovery programs to help providers, the community, and local organizations fight against the opioid epidemic.

Blue Cross Blue Shield of Arizona logo (PRNewsFoto/Blue Cross Blue Shield of Ari...)

In the state of Arizona alone, there were more than 8,500 suspected opioid overdoses and more than 1,500 suspected opioid deaths in the last year. As the numbers continue to climb and impact the health of Arizona families, BCBSAZ is stepping up in an effort to turn the tide against substance misuse.

"Opioid misuse continues to take a devastating toll in Arizona. While we have already made an incredible amount of progress to address this issue, more must be done," said Gov. Ducey. "This $10 million investment demonstrates Blue Cross Blue Shield of Arizona's continued commitment to public health and will further support the state's efforts in the fight against the opioid epidemic and substance use disorder."

Mobilize AZ includes more than a dozen strategies tailored to patients, doctors, and the community, including a grant program that will award a minimum of $1 million each year for three years to community organizations involved in education, treatment, and recovery. Grant applications are now open and will be accepted on an ongoing basis through a formal request-for-proposal process. Additionally, BCBSAZ will focus on expanding treatment resources and filling gaps through medication-assisted treatment (MAT), telehealth, and 24-hour triage to create a gateway to help for those in need.

"The opioid epidemic is one of the most significant public health and safety issues the state has faced in generations. Our vision is to bring together medical professionals, insurers, government, and the community to turn the tide against substance misuse, while showing compassion for those struggling with addiction and protecting those suffering from chronic pain," said Pam Kehaly, president and CEO of BCBSAZ. "Now is our time to act, and together we can heal and protect Arizona."

Helping to shape and guide the program is an advisory committee of leaders who represent Arizona's diverse communities. The committee works closely with the BCBSAZ Community Health Interventions Team to advise on priorities, review grant applications, and help monitor outcomes. 

Mobilize AZ embodies BCBSAZ's mission to improve the quality of life for all Arizonans. For almost 80 years, BCBSAZ has helped Arizonans protect their health and, in recent years, has worked to combat the opioid epidemic. The company, working in collaboration with its provider network, has reduced the number of opioid medications prescribed to members by 35 percent since 2013.

For more information and to join BCBSAZ in the fight against opioid misuse and substance use disorder, visit MobilizeAZ.com.

About Blue Cross Blue Shield of Arizona
Blue Cross Blue Shield of Arizona (BCBSAZ) is committed to helping Arizonans get healthier faster and stay healthier longer. With a focus on connecting people with the care they need, BCBSAZ offers health insurance and related services to nearly 1.5 million customers. BCBSAZ, a not-for-profit company, is an independent licensee of the Blue Cross Blue Shield Association. The company employs nearly 1,500 people in its Phoenix, Chandler, Flagstaff, and Tucson offices. Through advanced clinical programs and community outreach, BCBSAZ is moving health forward. To learn more, visit azblue.com.

 

SOURCE Blue Cross Blue Shield of Arizona


These press releases may also interest you

at 13:46
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced it has entered into distribution agreements for VETIGEL® to be sold through several leading regional distributors of...

at 13:26
Calliditas Therapeutics AB ,  ("Calliditas") today announces that the Annual Report for 2023 now is available at the company's website: www.calliditas.com For further information, please contact: Åsa Hillsten, Head of IR & Sustainability,...

at 13:07
Olympus, a global medical technology company committed to making people's lives healthier, safer, and more fulfilling, announced today data showing that the use of Narrow Band Imaging (NBI) technology with patients with non-muscle invasive bladder...

at 13:00
Dr. Benjamin Stong, a leading authority in facial plastic surgery based in Atlanta, has once again received recognition as...

at 13:00
TOPDON, the premier provider of cutting-edge technology and advanced tools for auto repair professionals and enthusiasts, just unveiled its latest in professional grade thermal imaging technology showcased in the new TS001. This long-focus Android...

at 12:46
AtaCor Medical Inc., a privately-held medical device company delivering the next generation of extravascular leads to advance the care of cardiac rhythm management (CRM) patients, announced today that it has completed a $28M Series C financing...



News published on and distributed by: